I-025

Interference Mix 3 (For Qualitative Use Only)

50-1000 μg/mL each component in acetonitrile, analytical standard, Cerilliant^®

• Synonym(e): Qualitative Interference Mixture
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: analytical standard
• Form: liquid
• Zusammensetzung: Aripiprazole, 100 μg/mL ; Lacosamide, 100 μg/mL ; Oxcarbazepine, 100 μg/mL ; (+)-Propoxyphene, 50 μg/mL ; Rufinamide, 100 μg/mL ; Warfarin, 1000 μg/mL
• Verpackung: ampule of 1 mL
• Hersteller/Markenname: Cerilliant^®
• drug control: estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
• Konzentration: 50-1000 μg/mL each component in acetonitrile
• Methode(n): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Anwendung(en): forensics and toxicology
• Format: multi-component solution
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcarbazepine; rufinamide; and warfarin. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Piktogramme: GHS02,GHS08,GHS07
• Signalwort: Danger
• H-Sätze: H225,H302 + H312 + H332,H319,H360D,H373
• P-Sätze: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 1A - STOT RE 2
• Zielorgane: Blood
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 35.6 °F - closed cup
• Flammpunkt (°C): 2.0 °C - closed cup